Many people dislike drug companies. Drug companies often charge a lot of money for their products. Sometimes their drugs dont work. Sometimes they have side effects. Sometimes they are addictive. Even the best drugs wont keep us alive forever.
But, during the coronavirus pandemic, we are relying on drug companies and other healthcare companies to save our lives and the lives of our loved ones.
While government plays a vital role in managing the response to the COVID-19 pandemic, its the private sector that will provide the solutions to identify and fight the disease. Who would you rather depend on profit-making private companies or bureaucratic government agencies?
The CDC response
In the United States, the Centers for Disease Control, a federal agency, was initially tasked with providing tests for COVID-19. Its test kits could not detect the difference between COVID-19 and lab-grade water.
The CDC also limited testing to patients who had recently traveled to China and were symptomatic. Whoops!
The lack of reliable test kits enabled the disease to spread throughout the United States. The U.S. Food and Drug Administration determined on Feb. 29 that certified labs, including commercial lab testing companies, could develop and distribute COVID-19 test kits.
Private companies and clinics stepped up quickly. Some examples:
The Cleveland Clinic developed an eight-hour test kit.
Hackensack Meridian Health developed a rapid response test kit that can provide results within a few hours.
On March 23, Everlywell became the first company to offer a test kit that consumers can use at home.
Roche shipped 400,000 test kits to labs across the United States beginning March 13, and an additional 400,000 the following week.
Thermo Fisher Scientific developed a test kit that can detect COVID-19 within four hours.
Drug companies in the United States and throughout the world are also working to develop a vaccine to fight COVID-19.
Cambridge-based Moderna Inc. has already begun Phase 1 testing of its mRNA-1273 vaccine that is based on the genetic sequence of COVID-19. Regeneron Pharmaceuticals of Tarrytown, New York, is working on an antibody treatment that uses the virus to build up antibodies that fight COVID-19. Inovio Pharmaceuticals of Plymouth Meeting, Pennsylvania., is developing INO-4800, a vaccine similar to Modernas that is made from optimized DNA plasmids.
But thats just a sample. At least 16 U.S. pharmaceutical companies are working on vaccines for COVID-19.
The government has been doing its part. President Trump declared a national emergency and Congress has been negotiating a massive spending bill, while the Federal Reserve Board dropped interest rates back to zero, resumed bond buying and provided liquidity to the banking system. None of these actions reassured investors and stopped the stock market from tanking. Recall that during the financial crisis, the Obama Administration invested more than $800 billion in a stimulus that stimulated the federal debt, but not the economy.
Communism vs. capitalism
While the government and private sector have both been working hard to battle the coronavirus, the Chinese government has been working hard to preserve the Communist Party by blaming the United States for the pandemic.
When Wuhan doctor Li Wenliang warned his colleagues in late December about a possible coronavirus that resembled SARS, local police reprimanded him for spreading rumors and he was called before a disciplinary council of the local Communist Party and forced to repent and confess, in writing, that he had spread rumors harmful to the glory of the Party, according to City Journal.
In early January, news of the virus started circulating on Chinese social media accounts. The government responded by shutting them down. By silencing news about the outbreak of COVID-19, Communist leaders allowed it to spread, resulting in the pandemic and thousands of deaths that could have been avoided.
Xu Zhiyong, an activist who criticized Chinese President Xi Jinpings response to the coronavirus, was jailed for subversion. Journalists Li Xehua, Fang Bin and Chen Qiushi, who tried to inform the public about the coronavirus outbreak, are all missing. And Western journalists who brought these stories to the worlds attention have been expelled from China.
Wuhan activists, professors and lawyers who had asked for President Xis resignation have all virtually disappeared. In addition to stifling the news at home, Chinas leaders failed to inform other countries about the severity of the coronavirus or to prevent its spread outside of China.
Should China be paying reparations to the rest of the world? Should it at least admit its guilt and apologize? According to an editorial in state-run media agency Xinhua, We should say righteously that the U.S. owes China an apology, the world owes China a thank you.
In addition, while the United States has shipped medical supplies to China to help fight the outbreak, China is threatening to impose export controls on pharmaceuticals needed by the U.S. to fight COVID-19.
In an article in Xinhua, Beijing bragged about its handling of COVID-19, according to Fox News. The article also claimed that China could impose pharmaceutical export controls which would plunge America into the mighty sea of coronavirus.
Without disclosing which drug or drugs are in short supply, the U.S. Food and Drug Administration announced a shortage of raw materials made in China that are needed to produce the drug.
While the United States is the world leader in medical research, China supplies 80% to 90% of antibiotics used in the United States, 70% of acetaminophen and about 40% of heparin, according to Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations.
Government vs. private sector
In other countries where health care is socialized, such as Italy and the United Kingdom, government responses have been underwhelming and politically charged.
Some 4,032 have died in Italy, more than in China, with 627 Italian deaths reported Friday (March 20) the highest daily toll for any country so far, according to The Wall Street Journal.
Which brings us back to the United States, where many Americans believe we would be better off with a socialized healthcare system. After all, many other countries have socialized medicine.
Some believe we should have price controls on drugs. Others believe that drug companies should not make profits and should make life-saving drugs available at no cost.
That belief would lead to no more life-savings drugs being developed, because there would be no incentive for companies to do so. Even if companies wanted to be able to give away free drugs, doing so would quickly put them out of business. Jobs would be eliminated and their stock would become worthless.
The average cost to develop a new drug is $2.6 billion. Post-approval research and development costs, such as the cost of monitoring effectiveness and safety, average $312 million and boost the total cost for each approved drug to almost $3 billion.
Most drugs never make it to market. Only about 12% of drugs that enter clinical testing are eventually approved for public use.
Some drug companies have made a great deal of money. Some have taken advantage of the drug-approval process and charged outrageous prices for their products.
Weve all heard about companies like Theranos, which achieved a valuation of $9 billion based on fraudulent blood-testing technology, or Mylans price gouging for its EpiPen. Companies in any industry that take advantage of their customers usually pay in the end, but in such cases, government involvement is necessary.
Regardless, even with no vaccine yet available, special interest groups that pretend that their interest is our interest are calling for President Trump to prohibit profiteering by Big Pharma during the coronavirus pandemic.
If Big Pharma develops a vaccine that works, the company that does so should make a significant profit. Is there a sector more deserving of a profit than one that saves lives? While small businesses are suffering most during the pandemic, large companies have also had to deal with major losses, a huge drop in their stock price and mounting expenses in an attempt to staunch the bleeding.
In 1900, 37% of all American deaths were from infectious diseases, George Will wrote. Today the figure is 2%.
Id rather the drug companies get a cut of my hard-earned money than the more than 70 groups that are trying to stop them from earning a profit. To my knowledge, none of the 70 groups has criticized President Xi.
Brenda P. Wenning of Newton is president of Wenning Investments LLC in Newton. She can be reached at Brenda@WenningInvestments.com or 617-965-0680. For additional information, visit her blog at http://www.WenningAdvice.com.
Link:
Drug companies are the good guys - MetroWest Daily News
- Department of Genetic Medicine - January 6th, 2025
- Research Services | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Patient Care | Johns Hopkins Department of Genetic Medicine - January 6th, 2025
- Specialty Clinics | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Pediatric Genetic Medicine at Johns Hopkins Children's Center - January 6th, 2025
- Research Centers | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- About Us - Johns Hopkins Medicine - January 6th, 2025
- Graduate Programs & Training | Johns Hopkins Medicine - January 6th, 2025
- Request an Appointment | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021